Effect of chronic treatment with Rosiglitazone on Leydig cell steroidogenesis in rats: In vivo and ex vivo studies

BACKGROUND: The present study was designed to examine the effect of chronic treatment with rosiglitazone - thiazolidinedione used in the treatment of type 2 diabetes mellitus for its insulin sensitizing effects - on the Leydig cell steroidogenic capacity and expression of the steroidogenic acute reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Couto, Janaína A, Saraiva, Karina LA, Barros, Cleiton D, Udrisar, Daniel P, Peixoto, Christina A, Vieira, Juliany SB César, Lima, Maria C, Galdino, Suely L, Pitta, Ivan R, Wanderley, Maria I
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829566/
https://www.ncbi.nlm.nih.gov/pubmed/20144211
http://dx.doi.org/10.1186/1477-7827-8-13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829566/
https://www.ncbi.nlm.nih.gov/pubmed/20144211
http://dx.doi.org/10.1186/1477-7827-8-13

Ejemplares similares